These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7575356)

  • 41. Regulation of interleukin-4 activity by soluble interleukin-4 receptors.
    Enssle K; Schulz G
    J Clin Lab Anal; 1995; 9(6):450-5. PubMed ID: 8587015
    [No Abstract]   [Full Text] [Related]  

  • 42. Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency.
    Tony HP; Shen BJ; Reusch P; Sebald W
    Eur J Biochem; 1994 Oct; 225(2):659-65. PubMed ID: 7957181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A computer model of the interleukin-4/receptor complex.
    Bamborough P; Grant GH; Hedgecock CJ; West SP; Richards WG
    Proteins; 1993 Sep; 17(1):11-9. PubMed ID: 8234241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interleukin 4 receptor (IL-4R)].
    Saito S
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():531-3. PubMed ID: 9172583
    [No Abstract]   [Full Text] [Related]  

  • 45. Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes.
    Junttila IS
    Front Immunol; 2018; 9():888. PubMed ID: 29930549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of immobilized synthetic peptides for the identification of contact sites between human interleukin-6 and its receptor.
    Weiergräber O; Schneider-Mergener J; Grötzinger J; Wollmer A; Küster A; Exner M; Heinrich PC
    FEBS Lett; 1996 Jan; 379(2):122-6. PubMed ID: 8635575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure/function analysis of interleukin 4: interspecies comparison and site-directed mutagenesis.
    Chapman CG; Clinkenbeard HE; Parker KE; Spackman VM; Dobbelaere DA; Robinson JH; Browne MJ
    Biochem Soc Trans; 1994 May; 22(2):234S. PubMed ID: 7958295
    [No Abstract]   [Full Text] [Related]  

  • 48. Molecular biology of T cell-derived lymphokines: structure and biology of interleukin 4.
    Arai N; Yokota T; de Vries J; Banchereau J; Takebe Y; Lee F; Arai K
    Dev Biol Stand; 1988; 69():57-63. PubMed ID: 3265679
    [No Abstract]   [Full Text] [Related]  

  • 49. Differential mechanisms of recognition and activation of interleukin-8 receptor subtypes.
    Suetomi K; Lu Z; Heck T; Wood TG; Prusak DJ; Dunn KJ; Navarro J
    J Biol Chem; 1999 Apr; 274(17):11768-72. PubMed ID: 10206993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction.
    Leong SR; Kabakoff RC; Hébert CA
    J Biol Chem; 1994 Jul; 269(30):19343-8. PubMed ID: 8034699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Three loops of the common gamma chain ectodomain required for the binding of interleukin-2 and interleukin-7.
    Olosz F; Malek TR
    J Biol Chem; 2000 Sep; 275(39):30100-5. PubMed ID: 10887198
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The interleukin-2 and interleukin-4 receptors studied by molecular modelling.
    Bamborough P; Hedgecock CJ; Richards WG
    Structure; 1994 Sep; 2(9):839-51. PubMed ID: 7529123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An antagonistic mutant of interleukin-4 fails to recruit gamma c into the receptor complex. Characterization by specific crosslinking.
    Duschl A
    Eur J Biochem; 1995 Mar; 228(2):305-10. PubMed ID: 7705343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic Targeting of the Interleukin-4/Interleukin-13 Signaling Pathway: In Allergy and Beyond.
    Karo-Atar D; Bitton A; Benhar I; Munitz A
    BioDrugs; 2018 Jun; 32(3):201-220. PubMed ID: 29736903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement.
    Kruse N; Tony HP; Sebald W
    EMBO J; 1992 Sep; 11(9):3237-44. PubMed ID: 1387082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional epitope of common gamma chain for interleukin-4 binding.
    Zhang JL; Buehner M; Sebald W
    Eur J Biochem; 2002 Mar; 269(5):1490-9. PubMed ID: 11874464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure and function of interleukin-4 and its receptor.
    Puri RK
    Cancer Treat Res; 1995; 80():143-85. PubMed ID: 8821577
    [No Abstract]   [Full Text] [Related]  

  • 58. The interleukin-4 site-2 epitope determining binding of the common receptor gamma chain.
    Letzelter F; Wang Y; Sebald W
    Eur J Biochem; 1998 Oct; 257(1):11-20. PubMed ID: 9799097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Making sense of the combined effect of interleukin-2 and interleukin-4 on lymphocytes using a mathematical model.
    Morel BF; Burke MA; Kalagnanam J; McCarthy SA; Tweardy DJ; Morel PA
    Bull Math Biol; 1996 May; 58(3):569-94. PubMed ID: 8688839
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of a human interleukin-6 receptor antagonist.
    Brakenhoff JP; de Hon FD; Fontaine V; ten Boekel E; Schooltink H; Rose-John S; Heinrich PC; Content J; Aarden LA
    J Biol Chem; 1994 Jan; 269(1):86-93. PubMed ID: 8276883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.